Arvinas logo
Close this search box.

Orally Administered PROTAC® Molecules Selectively Clear Pathologic Proteins in CNS & Muscle

Angela Cacace, Ph.D.

November 12, 2022
Society of Neuroscience 2022 Meeting


You are now leaving Arvinas does not endorse or recommend the content in any third-party sites. Arvinas is not responsible and disclaims liability for the content, or for any viruses or similar harmful programs, that may be present on third-party pages or sites. Visits to a third-party website are at your own risk and subject to the terms and conditions and privacy policy of such site.

Skip to content